$ Value
$3.3M
Shares
14,372
Price
$227
Filed
Dec 16
Insider
Name
ROSENMAN HERM
Title
—
CIK
0001230057
Roles
Transaction Details
Transaction Date
2025-12-12
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
54,389
Footnotes
Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $23,750 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. | Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.9450 to $226.9350 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.95 to $227.91 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.00 to $228.99 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Filing Info
ROSENMAN HERM's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-30 | NTRA | A | — |
| 2025-12-12 | NTRA | ▼ | $3.3M |
| 2025-12-12 | NTRA | ▼ | $5.0M |
| 2025-12-12 | NTRA | ▼ | $2.7M |
| 2025-12-12 | NTRA | ▼ | $34K |
| 2025-10-31 | NTRA | A | — |
| 2025-07-25 | NTRA | A | — |
| 2025-06-27 | NTRA | A | — |
| 2025-06-27 | NTRA | A | — |
| 2025-04-25 | NTRA | A | — |
Other Insiders at NTRA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BOTHA ROELOF | — | — | 2026-01-30 |
| ROSENMAN HERM | — | — | 2026-01-30 |
| Williams Brinkley Ruth | — | — | 2026-01-30 |
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
|
— | $38.3M | 2026-04-06 |
| Sheena Jonathan | — | $2.4M | 2026-04-17 |
| Baynes Roy D. | — | — | 2026-01-30 |
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
|
— | $2.9M | 2026-03-10 |
| Marcus Gail Boxer | — | — | 2026-01-30 |
|
Chapman Steven Leonard
CEO AND PRESIDENT
|
— | $24.1M | 2026-03-10 |
| Bertagnolli Monica | — | — | 2026-01-30 |
| Chapman Rowan E | — | $23K | 2026-03-13 |
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
|
— | $4.5M | 2026-04-01 |
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
|
— | $3.0M | 2026-04-01 |
|
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
|
— | $1.4M | 2026-03-10 |